http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19832169-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5fe74855697fef20a2e98a9b005db19
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
filingDate 1998-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73643faaad5f510d4f2605c79a17b333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba3cbd43030b2301e28de0870bc439ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10da0cc983e73699bc4503932f004c1b
publicationDate 2000-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-19832169-A1
titleOfInvention Locally applicable pharmaceutical preparations for the prophylaxis and therapy of atrophic phenomena in the oral cavity
abstract The present invention relates to locally applicable, non-systematic, pharmaceutical preparations for the prophylaxis and treatment of atrophic phenomena in the oral cavity, such as marginal dental disease, so that in the long term Altersparadontose with tooth loosening and a decline in the gingiva of the tooth necks can be excluded and the application of Dentures will be in decline. DOLLAR A These pharmaceutical preparations contain estrogenic agents - at least one active ingredient from the group 17alpha-estradiol, 17beta-estradiol, estriol, estrone or their chemically modified derivatives - which are present in low concentration in local dressings (creams, gels) and / or mouth-specific from the oral mucosa well absorbable dosage forms, which provide the active ingredients, for example, lingual, sublingual, peridontal or buccal, are processed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005110358-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005110358-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0067708-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1350513-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03084548-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0067708-A3
priorityDate 1998-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19646392-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757

Total number of triples: 32.